journal article·2015-02

Collagen‐lactoferrin fibrillar coatings enhance osteoblast proliferation and differentiation

Marta Vandrovcova, Timothy E. L. Douglas, Sascha Heinemann, Dieter Scharnweber, Peter Dubruel, Lucie Bacakova

Publisher page

Abstract

Abstract Lactoferrin is a milk‐derived glycoprotein with anabolic effects on the bone tissue. In this study, artificial extracellular matrices (aECM) consisting of collagen type I fibrils formed in the presence of lactoferrin at two different concentrations (0.5 and 1 mg mL−1) were prepared on the surface of poly(lactic‐co‐glycolic acid) (PLGA) foils. The aim of the study was to investigate the effects of aECM on the adhesion, growth and osteogenic differentiation of human osteoblast‐like Saos‐2 cells. On days 1 and 3 after seeding, higher numbers of cells were found on samples with collagen and collagen‐lactoferrin coatings (particularly on those formed at the higher concentration of lacroferrin) than on control microscopic glass coverslips. Cells on coatings formed in the presence of lactoferrin had more numerous and better developed vinculin‐containing focal adhesion plaques. On day 7, cells on coatings with and without lactoferrin produced significantly higher levels of osteocalcin than cells on control polystyrene cell culture dishes, the highest average values being found on samples with the lower concentration of lactoferrin. Expression of collagen I and alkaline phosphatase was on a similar level in cells on all tested samples and control polystyrene. Thus, lactoferrin promotes adhesion, growth and osteogenic differentiation of Saos‐2 cells and is promising as a bone implant coating component. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 525–533, 2015.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Infant Nutrition and Health · Tissue Engineering and Regenerative Medicine · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomaterials and Tissue Engineering Institute of Physiology, Academy of Sciences of the Czech Republic Videnska 1083, 14220 Prague 4 Czech Republic

Polymer Chemistry and Biomaterials (PBM) Group, Department of Organic Chemistry Ghent University Krijgslaan 281 S4 9000 Ghent Belgium

Biomimetic Materials and Biomaterial Analytics Group, Institute of Material Science, Max Bergmann Center of Biomaterials Technische Universität Dresden Budapester Strasse 27 01069 Dresden Germany

Biomaterial Development Group, Institute of Material Science, Max Bergmann Center of Biomaterials Technische Universität Dresden Budapester Strasse 27 01069 Dresden Germany

Funding

Grant Agency of the Czech Republic

References (37)

Show source-provided references
1. 10.3121/cmr.3.2.9310.3121/cmr.3.2.93 ↗
2. 10.1016/j.biochi.2008.05.00610.1016/j.biochi.2008.05.006 ↗
3. 10.1210/en.2003-130710.1210/en.2003-1307 ↗
4. 10.1163/092050610X51709510.1163/092050610X517095 ↗
5. 10.1016/j.cellbi.2008.11.01310.1016/j.cellbi.2008.11.013 ↗
6. 10.1016/j.mce.2006.03.00210.1016/j.mce.2006.03.002 ↗
7. 10.1016/j.biomaterials.2006.01.02910.1016/j.biomaterials.2006.01.029 ↗
8. 10.1007/s10534-011-9423-810.1007/s10534-011-9423-8 ↗
9. Influence of collagen and chondroitin sulfate (CS) coatings on poly‐(lactide‐co‐glycolide) (PLGA) on MG 63 osteoblast‐like cells10.33549/physiolres.931994 ↗
10. 10.1115/1.400019410.1115/1.4000194 ↗
11. Surface characterization, collagen adsorption and cell behaviour on poly(l ‐lactide‐co‐glycolide)
12. 10.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-710.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-7 ↗
13. 10.1021/bm060964410.1021/bm0609644 ↗
14. 10.1002/jbm.a.3081410.1002/jbm.a.30814 ↗
15. 10.1002/jbm.a.3057210.1002/jbm.a.30572 ↗
16. 10.1038/nature0887110.1038/nature08871 ↗
17. 10.1002/jcb.1017410.1002/jcb.10174 ↗
18. 10.1373/clinchem.2008.11279710.1373/clinchem.2008.112797 ↗
19. 10.1042/bj096071010.1042/bj0960710 ↗
20. 10.1111/j.1432-1033.1973.tb02695.x10.1111/j.1432-1033.1973.tb02695.x ↗
21. 10.1016/0014-5793(75)80133-510.1016/0014-5793(75)80133-5 ↗
22. 10.1016/0142-9612(93)90135-O10.1016/0142-9612(93)90135-O ↗
23. 10.1016/0142-9612(95)94149-F10.1016/0142-9612(95)94149-F ↗
24. 10.1016/0142-9612(96)89663-310.1016/0142-9612(96)89663-3 ↗
25. 10.1016/0892-0354(90)90018-N10.1016/0892-0354(90)90018-N ↗
26. 10.17221/1978-VETMED10.17221/1978-VETMED ↗
27. 10.1139/o2012-01610.1139/o2012-016 ↗
28. 10.1023/B:BIOM.0000027713.18694.9110.1023/B:BIOM.0000027713.18694.91 ↗
29. 10.1007/s00264-011-1303-x10.1007/s00264-011-1303-x ↗
30. 10.1254/jphs.FP007072810.1254/jphs.FP0070728 ↗
31. 10.1074/jbc.M60497420010.1074/jbc.M604974200 ↗
32. 10.1007/s00198-011-1614-110.1007/s00198-011-1614-1 ↗
33. 10.1016/j.jbiosc.2008.09.01810.1016/j.jbiosc.2008.09.018 ↗
34. 10.1016/j.actbio.2011.07.01910.1016/j.actbio.2011.07.019 ↗
35. 10.1271/bbb.7046510.1271/bbb.70465 ↗
36. 10.1089/ten.tea.2012.022710.1089/ten.tea.2012.0227 ↗
37. 10.1071/RD0600110.1071/RD06001 ↗